Press release
Precision Antibody's CEO to Speak at 23rd BioPharma Drug Discovery Nexus in San Francisco
Columbia, MD-May 5, 2025-Precision Antibody, a trusted leader in the development of custom monoclonal antibodies, proudly announces that its CEO, Dr. Ginette Serrero, will speak at the upcoming 23rd BioPharma Drug Discovery Nexus, taking place May 7-8, 2025, at Embassy Suites by Hilton in San Francisco, California.The BioPharma Drug Discovery Nexus (DDN) is an international forum that brings together top experts, researchers, and innovators in drug discovery and development. The event explores the latest technologies and strategies driving breakthroughs in early-stage drug development, translational science, and biologics.
Dr. Lin will speak on the importance of producing high-affinity, high-specificity monoclonal antibodies in early-stage drug discovery and how Precision Antibody's proven processes help researchers generate reliable data-fast.
"Our commitment is to help researchers accelerate discovery by providing antibodies that work right the first time," said Dr. Serrero. "I look forward to joining fellow thought leaders at BioPharma Drug Discovery Nexus to share best practices and forward-looking perspectives on antibody development."
Dr. Serrero's decades of experience in monoclonal antibody production and Precision Antibody's track record of speed and success position the company as a key enabler of translational and therapeutic discovery programs in academia and industry.
About Precision Antibody
The company has more than two decades of experience providing personalized services for monoclonal and polyclonal antibody development. Founded in 2000, it is now a global leader in delivering solutions for therapeutic and research purposes. It is also equipped to tackle antibody requirements for oncology, immunology, and regenerative medicine. The company deals with academic research centers and worldwide pharma companies.
Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: info@precisionantibody.com
Website: www.precisionantibody.com
Event Details:
BioPharma Drug Discovery Nexus (DDN US)
Dates: May 7 - 8, 2025
Venue: Embassy Suites by Hilton in San Francisco, CA
Event Website: https://nexus-conference.com/ddnus/
9130 Red Branch Road, Suite X, Columbia, MD 21045
Precision Antibody is located in an 11,000 sq ft AAALAC and OLAW certified facility in Columbia, in the biotech corridor of the State of Maryland, USA. We are proud to be offering the highest quality service to our customer in the US and all over the world. All our operations are performed at our site. We do not outsource any of our work to foreign countries where the cost can be less expensive.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Precision Antibody's CEO to Speak at 23rd BioPharma Drug Discovery Nexus in San Francisco here
News-ID: 4000178 • Views: …
More Releases from Precision Antibody
Precision Antibody Leads the Future of Antibody-Based Therapeutics by Partnering …
Baltimore, MD-Oct 20, 2024: Precision Antibody, a leading provider of custom monoclonal antibody discovery and development services, is excited to announce its sponsorship of the 17th Drug Discovery Strategic Summit (DDSS), to be held on October 23-24, 2024, at the Leonardo Hotel Munich Arabellapark in Munich, Germany.
The 17th DDSS is designed to promote collaboration, knowledge-sharing, and innovation in the pharmaceutical and biotech industries. The summit offers an immersive experience…
More Releases for BioPharma
Biopharma Outsourcing Market to See Massive Growth by 2029 | Keyrus Biopharma, E …
According to HTF Market Intelligence, the Global Biopharma Outsourcing market to witness a CAGR of 10.68% during the forecast period (2023-2029). The Latest Released Biopharma Outsourcing Market Research assesses the future growth potential of the Biopharma Outsourcing market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
Global Biopharma Outsourcing Market 2022 Future Set to Massive Growth | Major Pl …
The "Global Biopharma Outsourcing Market Analysis to 2030" is a particular and top to bottom analysis of the Biopharma Outsourcing industry with an emphasis on the worldwide market trend. The report expects to provide an overview of worldwide Biopharma Outsourcing market detailed market segmentation by service, organization mode, application and geography. The worldwide Biopharma Outsourcing market is predictable to witness high growth during the forecast period. The report gives key…
Biopharma Outsourcing Global Market Outlook - BioPharma Services, Lambda Therape …
The Biopharma Outsourcing Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Biopharma Outsourcing market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of…
Biopharma Outsourcing Market Outlook to 2025: Sartorius, Emcure Pharmaceuticals, …
Biopharma Outsourcing market is also presented to the readers as a holistic snapshot of the competitive landscape within the given forecast period. The report also educates about the market strategies that are being adopted by your competitors and leading organizations. The report also focuses on all the recent industry trends. It presents a comparative detailed analysis of the all regional and player segments, offering readers a better knowledge of where…
Biopharma Outsourcing Market Future Analysis to 2023 |Sartorius, Emcure Pharmace …
According to the Biopharma Outsourcing Market report, the global market is expected to witness a relatively higher growth rate during the forecast period. This Biopharma Outsourcing Market Report cover strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and…
Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 …
WiseGuyReports.Com Publish a New Market Research Report On –“ Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 | Key Players : Sartorius, Emcure Pharmaceuticals, BioPharma Services, Baxter Healthcare, Keyrus Biopharma, Quintiles”.
Description:-
Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base.
Scope of the Report:
This market encompasses various contract companies that provide clinical trials, drug…
